IMT as first line therapy in VKH

Post here with questions about other autoimmune diseases or conditions.

Moderators: Mike Bartolatz, kwork

Post Reply
Mike Bartolatz
Posts: 6595
Joined: Fri Feb 06, 2004 9:58 pm

IMT as first line therapy in VKH

Post by Mike Bartolatz »

Ocul Immunol Inflamm. 2006 Apr;14(2):87-90. Links
Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy.Paredes I, Ahmed M, Foster CS.
Massachusetts Eye and Ear Institute, Department of Ophthalmology, Harvard Medical School, Boston, MA 02114, USA.

PURPOSE: To report on the use of immunomodulatory therapy (IMT) in a group of patients with Vogt-Koyanagi-Harada disease (VKH) and to compare the outcomes with those of another group of patients with VKH who were treated for prolonged periods with corticosteroids. METHODS: Treatment regimens and their respective outcomes (visual acuity) were compared for the following groups: prolonged steroid with or without delayed addition of IMT (Group 1) and relatively prompt IMT with or without steroid (Group 2). RESULTS: The average duration of follow-up in Group 1 was 28.9 months and in Group 2 23.4 months. In Group 1, visual acuity deteriorated in three of the five patients (60%) and improved in one (20%). The fifth patient showed improvement in visual acuity in one eye, but decreased visual acuity in the other eye. In Group 2, seven of the eight patients showed improvement in their visual acuities (87.5%); visual acuity deteriorated in one patient (12.5%). CONCLUSIONS: The results suggest that IMT as first-line therapy for VKH is associated with a superior visual outcome when compared to steroid as monotherapy or with delayed addition of IMT.

PMID: 16597537 [PubMed - indexed for MEDLINE]
Related LinksManagement of pediatric Vogt-Koyanagi- Harada (VKH)-associated panuveitis. [Ocul Immunol Inflamm. 2006] PMID: 16597538 Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. [Am J Ophthalmol. 2006] PMID: 16815259 Outcomes of treatment with immunomodulatory therapy in patients with corticosteroid-resistant juvenile idiopathic arthritis-associated chronic iridocyclitis. [Ocul Immunol Inflamm. 2005] PMID: 16419420 Vogt-Koyanagi-Harada disease in Thai patients. [J Med Assoc Thai. 2005] PMID: 16681048 Vogt-Koyanagi-Harada disease: clinical outcomes. [Am J Ophthalmol. 2005] PMID: 16226518 See all Related Articles...
Mike Bartolatz
Moderator
Post Reply